Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| 1 |
Jefferies Financial Group
JEF
|
+$501M |
| 2 |
Palo Alto Networks
PANW
|
+$350M |
| 3 |
SPDR S&P Biotech ETF
XBI
|
+$306M |
| 4 |
Financial Select Sector SPDR Fund
XLF
|
+$290M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$262M |
Top Sells
| 1 |
Caterpillar
CAT
|
+$706M |
| 2 |
Apple
AAPL
|
+$683M |
| 3 |
Microsoft
MSFT
|
+$667M |
| 4 |
Flutter Entertainment
FLUT
|
+$586M |
| 5 |
NVIDIA
NVDA
|
+$499M |
Sector Composition
| 1 | Technology | 28.6% |
| 2 | Consumer Discretionary | 11.44% |
| 3 | Financials | 10.48% |
| 4 | Healthcare | 7.65% |
| 5 | Communication Services | 6.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Esquire Financial Holdings
ESQ
$823M
| $449K | ﹤0.01% |
5,650
+522
| +10% | +$41.5K |
|
|
BOW
3002
Bowhead Specialty Holdings
BOW
$970M
| $449K | ﹤0.01% |
12,644
+3,782
| +43% | +$134K |
|
3003
EverQuote
EVER
$899M
| $449K | ﹤0.01% |
22,461
+4,174
| +23% | +$83.4K |
|
3004
Xeris Biopharma Holdings
XERS
$1.19B
| $449K | ﹤0.01% |
132,446
+13,019
| +11% | +$44.1K |
|
3005
JFrog
FROG
$5.81B
| $449K | ﹤0.01% |
15,252
+4,639
| +44% | +$136K |
|
3006
Lakeland Industries
LAKE
$139M
| $447K | ﹤0.01% |
17,512
-5,792
| -25% | -$148K |
|
3007
TruBridge
TBRG
$302M
| $447K | ﹤0.01% |
22,646
-14,453
| -39% | -$285K |
|
3008
Ryerson Holding
RYI
$742M
| $446K | ﹤0.01% |
24,087
+2,151
| +10% | +$39.8K |
|
3009
Metals Acquisition
MTAL
$1.01B
| $446K | ﹤0.01% |
41,957
+2,827
| +7% | +$30K |
|
|
ETWO
3010
DELISTED
E2open Parent Holdings
ETWO
| $445K | ﹤0.01% |
167,295
+16,646
| +11% | +$44.3K |
|
3011
ZipRecruiter
ZIP
$421M
| $445K | ﹤0.01% |
61,461
+9,182
| +18% | +$66.5K |
|
3012
A-Mark Precious Metals
AMRK
$663M
| $443K | ﹤0.01% |
16,175
+3,178
| +24% | +$87.1K |
|
3013
Capital City Bank Group
CCBG
$743M
| $443K | ﹤0.01% |
12,089
+1,483
| +14% | +$54.4K |
|
3014
Evolv Technologies
EVLV
$1.47B
| $443K | ﹤0.01% |
112,069
+17,312
| +18% | +$68.4K |
|
3015
i3 Verticals
IIIV
$734M
| $442K | ﹤0.01% |
19,189
+2,581
| +16% | +$59.5K |
|
|
NYAX
3016
Nayax
NYAX
$1.8B
| $440K | ﹤0.01% |
15,001
+14,996
| +299,920% | +$440K |
|
|
DHC
3017
Diversified Healthcare Trust
DHC
$1.08B
| $440K | ﹤0.01% |
191,349
+17,043
| +10% | +$39.2K |
|
3018
Taysha Gene Therapies
TSHA
$818M
| $438K | ﹤0.01% |
253,292
+120,680
| +91% | +$209K |
|
3019
Omeros
OMER
$280M
| $436K | ﹤0.01% |
44,175
+3,128
| +8% | +$30.9K |
|
3020
Sana Biotechnology
SANA
$797M
| $436K | ﹤0.01% |
267,510
+162,365
| +154% | +$265K |
|
|
UPB
3021
Upstream Bio, Inc. Common Stock
UPB
$918M
| $436K | ﹤0.01% |
+26,504
| New | +$436K |
|
3022
PACS Group
PACS
$1.56B
| $435K | ﹤0.01% |
33,206
+4,241
| +15% | +$55.6K |
|
3023
P10
PX
$1.33B
| $435K | ﹤0.01% |
34,521
+3,706
| +12% | +$46.7K |
|
3024
Pacific Biosciences
PACB
$348M
| $435K | ﹤0.01% |
237,691
+8,591
| +4% | +$15.7K |
|
3025
Standard BioTools
LAB
$493M
| $434K | ﹤0.01% |
247,855
+17,230
| +7% | +$30.2K |
|